
IIT Guwahati launches 4-year biomedical science programme, admissions begin soon
The Indian Institute of Technology (IIT) Guwahati has launched a new four-year Bachelor of Science (BS) degree in Biomedical Science and Engineering. The course will be conducted by the Jyoti and Bhupat Mehta School of Health Sciences and Technology (JBMSHST).This course incorporates the expertise of IIT Guwahati, AIIMS Guwahati, and NIPER Guwahati. Practical learning, experience in clinics, and special subjects that connect medicine and technology are what students will learn. What makes this course special is the emphasis on learning through actual experience with doctors and scientists.advertisementThe launch ceremony was witnessed by several experienced scholars such as IIT Guwahati Director Prof. Devendra Jalihal, AIIMS Guwahati Director Prof. Ashok Puranik, and NIPER Guwahati Director Professor USN Murty.
Participants from the Mehta Family Foundation (USA), who are sponsoring this cause, joined virtually.Professor Jalihal explained that the course is for those who are keen to address real health issues with engineering and medicine. He added that this course is designed to prepare professionals to come up with new healthcare solutions.APPLICATION AND ELIGIBILITY DETAILSApplications for the course will be open from April 25, 2025, to May 25, 2025. Students who are interested in this course can check the IIT Guwahati website for details.The course includes topics such as bioinstrumentation, sensors, wearable devices, and AI in medicine. One can opt for further study in advanced topics such as neuroscience and personalised medicine after three years.advertisementTo be eligible, the students should have already cleared Class 12 in 2024 or 2025 with Physics, Chemistry, Maths, and Biology, and should obtain a minimum of 75% marks. Students who clear the IISER Aptitude Test 2025 are also eligible.This new course is designed to produce a new generation of health professionals who will be able to contribute meaningfully to the health and medical field.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
3 days ago
- Time of India
IIT Guwahati harnesses clay sedimentation to identify and measure Coronavirus
Guwahati: Indian Institute of Technology Guwahati researchers have developed a novel method for detecting and measuring the amount of SARS-CoV-2, the virus that causes COVID-19. The innovative approach is based on how quickly a clay-virus-electrolyte mixture settles; a process commonly known as sedimentation, offering a simple and affordable alternative to the complex and expensive methods currently in use for virus detection. The findings of this research have been published in the prestigious peer-reviewed journal, Applied Clay Science, in a paper co-authored by Prof. T V Bharat, Department of Civil Engineering, and Prof. Sachin Kumar, Department of Biosciences and Bioengineering, along with research scholars Dr Himanshu Yadav and Deepa Mehta at IIT Guwahati . Posing a threat to human lives globally, COVID-19 pandemic revealed a critical gap in how viral infections are detected and tracked. Current methods, such as Polymerase Chain Reaction (PCR), are highly sensitive but time-consuming and require heavy equipment. Similarly, the antigen testing is fast but lacks accuracy, while antibody testing is used after the infection has occurred, highlighting limitations at various levels. Additionally, many of these methods are not practical in resource-limited settings or during large-scale outbreaks. To address these gaps, Prof. T V Bharat, Dept. of Civil Engineering, IIT Guwahati, along with his research team has used Bentonite clay, a clay well known for its ability to absorb pollutants and heavy metals due to its unique chemical structure in collaboration with Prof. Sachin Kumar, Department of Biosciences and Bioengineering. Previous studies have shown that clay particles can bind with viruses and bacteriophages, making it a promising material for virus detection. The research team focused on how Bentonite clay interacts with virus particles in a salt environment. The research team found that a Coronavirus surrogate and Infectious Bronchitis Virus (IBV) bind to the negatively charged clay surfaces at a controlled room temperature and a neutral pH of 7. Speaking about the findings of the research, Prof. T V Bharat said, "Imagine a world where detecting viruses is as simple as watching sand settle in water. That is the breakthrough we have achieved! Our new method uses clay to quickly identify and measure viruses, like the coronavirus. By observing how the clay settles in a solution, we can determine if a virus is present and how much of it there is. This innovative approach offers a faster, more affordable, and accurate alternative to current methods, paving the way for better disease monitoring and treatment strategies, especially during pandemics, this study is in continuation with our recent studies published in prestigious journals like Langmuir in developing exclusive biomedical waste facilities for disposing pathogenic waste sponsored by Department of Science and Technology, Government of India." The research team validated their findings using established virus-detection methods, including plaque assay for a coronavirus surrogate and RT-PCR for IBV. The developed technique produced accurate results in comparison to the standard detection methods, reinforcing its reliability. Notably, the method can be extended to detect other viruses such as the Newcastle Disease Virus (NDV), which affects poultry and causes major losses in the farming industry. This development holds great promise for improving how viral outbreaks are monitored and controlled, especially in regions where expensive lab equipment and trained personnel are not readily available. With further refinement, the method could be adapted for use in field kits or simple laboratory setups, making virus detection more accessible and efficient in future public health emergencies. As the next step, the research team is planning to collaborate with industry partners with medical facilities for clinical trials for SARS-Cov-2 and other viruses. By partnering with industry, the research team hopes to leverage the resources and expertise necessary to conduct robust clinical trials and ultimately contribute to the global effort to combat viral infections.


India Today
3 days ago
- India Today
IIT Guwahati develops low-cost way to measure COVID-19 using clay
A research team at IIT Guwahati has come up with a new way to detect the virus that causes COVID-19 -- using clay and salt water. This method doesn't rely on heavy lab equipment or complex tests. Instead, it watches how a mix of clay, virus, and salt water settles over time, a process known as study, led by Professor TV Bharat from the Department of Civil Engineering and Professor Sachin Kumar from the Department of Biosciences and Bioengineering, explores the use of Bentonite for sticking to pollutants, this clay also binds with viruses when placed in the right environment -- room temperature and a neutral pH.'Think of it like watching mud settle in a glass of water,' Prof. Bharat explained. 'The way the clay falls can tell us if a virus is there and how much of it is present.'The team tested the method using a virus similar to coronavirus and the Infectious Bronchitis Virus (IBV). They checked the results using existing detection tools like RT-PCR and plaque assays. The clay-based approach gave matching results -- without the need for expensive method could be useful not just for detecting COVID-19 but also other viruses, like those affecting poultry farms. It could be especially handy in places that don't have access to high-end researchers now plan to team up with medical labs and industry players to test this approach on real-world samples. If all goes well, they hope to turn it into a simple field kit for future idea -- watching how fast clay sinks -- could become part of how we deal with virus outbreaks in the future, especially in areas that need quick, low-cost solutions. advertisement


Time of India
3 days ago
- Time of India
India's Covid cases cross 5,000 mark as new variant spreads: Kerala leads surge, Maharashtra, Delhi follow
India has recorded over 5,300 active COVID-19 cases amid a slow but visible resurgence. The increase is attributed to new variants like NB.1.8.1 and LF.7, with Kerala, Gujarat, and West Bengal reporting the highest numbers. The Centre has directed mock drills and equipment checks nationwide. Most cases are mild, but officials urge vigilance. Researchers at IIT Guwahati have also introduced a new virus detection method. States like Odisha, Maharashtra, and Haryana are issuing public advisories and preparing for possible outbreaks. Tired of too many ads? Remove Ads Kerala leads surge, Maharashtra and Delhi follow Tired of too many ads? Remove Ads Localised spikes in Haryana, Odisha, and Uttarakhand Technical reviews and national mock drills Variant NB.1.8.1 drives global spread Tired of too many ads? Remove Ads Symptoms and vaccine efficacy Research breakthrough at IIT Guwahati India's active Covid-19 caseload reached 5,364 on Friday, with 764 new cases and four deaths recorded in the past 24 hours, according to data from the Union Health Ministry . Kerala, Gujarat, West Bengal, and Delhi emerged as key hotspots. The rising trend has led the Centre to conduct hospital preparedness drills and instruct all states to bolster oxygen supplies, ventilators, isolation wards, and stockpiles of essential new cases remain mild and are being managed at home. However, the emergence of the NB.1.8.1 variant — now under global monitoring — has raised questions about increased continues to report the highest number of cases. In the last 24 hours alone, it registered 192 infections. Gujarat followed with 107, while West Bengal and Delhi reported 58 and 30 new cases added 114 cases on Friday, with the state's total since January rising to 1,276. One new death was confirmed, bringing the toll to 18. Most of the deceased had comorbidities, according to the state health Delhi, the active caseload rose to 592. No new deaths were recorded since Thursday, with seven fatalities since January 1. The capital is yet to see a sharp spike but remains on logged 31 new infections on Friday. Gurugram and Faridabad contributed 20 cases between them. The state has 87 active cases and a total of 151 cumulative infections. 'Timely action and strict adherence to preventive measures can significantly curb the spread of the virus,' said Health Minister Arti Singh Rao, urging the public to stay alert but reported seven new cases, raising the total to 30 this wave. Public Health Director Nilakantha Mishra noted that 'on average, five to seven new cases are being detected every day.' He added, 'We all have to remain cautious.'The state is considering fresh guidelines in schools when they reopen on 20 June. 'Students with Covid-like symptoms would be asked to wear masks in schools, while those with more acute signs of the infection would be asked to stay home,' said School and Mass Education Minister Nityananda Uttarakhand, seven people tested positive in Dehradun, bringing the district's count to 29. The health department is tracing contacts of the newly Union Health Ministry, led by DGHS Dr Sunita Sharma, held back-to-back technical review meetings on 2 and 3 June. Attendees included representatives from the NCDC, ICMR, IDSP, EMR Cell, and officials from all states and union territories. The meetings focused on preparedness and assessing the national 5 June, hospitals across India carried out a mock drill. The focus was on checking oxygen systems, including PSA plants and liquid medical oxygen current wave in India is being primarily fuelled by the NB.1.8.1 variant, a recombinant strain of Omicron. According to the World Health Organization, it was declared a 'variant under monitoring' on 23 May 2025. By April, it made up over 10% of sequences globally — up from 2.5% a month Lara Herrero wrote in The Conversation that NB.1.8.1 has shown a stronger ability to bind to human cell receptors. 'It may infect cells more efficiently than earlier strains,' she noted.'It is more transmissible,' confirmed Prof. Subhash Verma, from the University of Nevada's School of Medicine, in an interview with CBS symptoms of the NB.1.8.1 variant include sore throat, cough, fever, muscle pain, and nasal congestion. Some patients have also reported nausea and stress that vaccines remain crucial. While NB.1.8.1 may partially evade immunity, current vaccines still help reduce severe illness and hospitalisation.'There is no evidence that the new strain is more severe or deadly,' said public health officials. However, they advise testing, masking, and distancing if symptoms the ongoing surge, researchers at IIT Guwahati have introduced a new method to detect and quantify SARS-CoV-2. It's based on sedimentation — the settling of a clay-virus-electrolyte mix. This cost-effective approach was developed by Prof. T V Bharat and Prof. Sachin Kumar, alongside scholars Dr Himanshu Yadav and Deepa findings, now published in Applied Clay Science, may provide a useful tool for rapid testing in areas with limited access to conventional diagnostic far, most Covid-19 cases reported this year are mild. Of the 55 deaths since January 1, nearly all occurred among those with pre-existing health governments are issuing region-specific advisories. In Odisha, for instance, health services director Amarendra Nath Mohanty advised people with symptoms to avoid visiting Puri during the upcoming Rath Yatra. 'Such persons can witness the festival through television and other media platforms,' he West Bengal, where 58 new cases and 91 recoveries were recorded, officials said, 'The situation is under control, and there is nothing to worry about. However, we would advise the people to follow the Covid-19 health-related protocols and wear masks.'The resurgence of Covid-19 in India reflects a broader global trend. New strains continue to evolve, and while many remain mild, health systems must stay ready. The coming weeks may offer clarity on the behaviour of NB.1.8.1 and LF.7 then, authorities are focused on readiness. Clinicians urge the public to remain aware but not anxious. Testing, vaccines, and responsible public behaviour remain the best defence.